Back to funds

Cormorant Asset Management, LP

Updated 6 days ago

Managed by Cormorant Asset Management, Lp • Latest filing Q3 2026

Portfolio value
$1.5B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$2.2B
Q1 2026$2B
Q2 2026$2B
Q3 2026$1.5B

Top holdings

60 positions as of Q3 2026

View filing
P

PARABILIS MEDICINES INC

Value
$149M
Shares
4.62M
% Port
10.01%
P

PRAXIS PRECISION MEDICINES I

Value
$145.6M
Shares
500.0K
% Port
9.78%
R

RAPPORT THERAPEUTICS INC

Value
$82.6M
Shares
2.46M
% Port
5.54%
E

EDGEWISE THERAPEUTICS INC

Value
$75.5M
Shares
1.86M
% Port
5.07%
?
5.N/A

BRIDGEBIO ONCOLOGY THERAPEUT

Value
$73.3M
Shares
17.88M
% Port
4.92%
E

ERASCA INC

Value
$73.3M
Shares
5.00M
% Port
4.92%
?
7.N/A

BLOSSOMHILL THERAPEUTICS INC

Value
$67.4M
Shares
3.61M
% Port
4.52%
A

ADLAI NORTYE GROUP LTD

Value
$63.7M
Shares
3.98M
% Port
4.27%
D

DIANTHUS THERAPEUTICS INC

Value
$44M
Shares
500.0K
% Port
2.96%
A

ABIVAX SA

Value
$42.1M
Shares
425.0K
% Port
2.83%
D

BRIGHT MINDS BIOSCIENCES INC

Value
$39.9M
Shares
800.0K
% Port
2.68%
?
12.N/A

ELECTRA THERAPEUTICS INC

Value
$37.9M
Shares
3.37M
% Port
2.54%
M

MOONLAKE IMMUNOTHERAPEUTICS

Value
$33.4M
Shares
2.86M
% Port
2.24%
O

ORUKA THERAPEUTICS INC

Value
$33.3M
Shares
400.0K
% Port
2.24%
?
15.N/A

ATTOVIA THERAPEUTICS INC

Value
$30.7M
Shares
1.79M
% Port
2.06%
F

FAETH THERAPEUTICS INC

Value
$30.6M
Shares
1.03M
% Port
2.05%
?
17.N/A

LATIGO BIOTHERAPEUTICS INC

Value
$30.3M
Shares
1.82M
% Port
2.04%
A

AGOMAB THERAPEUTICS NV

Value
$27.4M
Shares
2.47M
% Port
1.84%
I

OPUS GENETICS INC

Value
$26.6M
Shares
5.50M
% Port
1.79%
?
20.N/A

CLIMB BIO INC

Value
$24.2M
Shares
2.11M
% Port
1.62%

Explore